|
Dimercaptosuccinic acid,2418-14-6 |
|
|
CAS |
2418-14-6 |
Molecular Formula |
C4H6O4S2 |
Molecular Weight |
182.219 |
Systematic Name |
Succinic acid, 2,3-dimercapto- ; DMSA |
Assay |
99% |
Certificate of analysis |
|
View via PDF file |
|
Specification |
|
|
|
|
Items |
Specification |
Test result |
|
|
Complies |
Melting Point |
>190℃ |
196~197℃ |
pH |
2.4 to 2.6 |
2.5 |
Heavy metals |
Not more than 10ppm |
Complies |
Reside on ignition |
Not more than 0.1% |
Complies |
Loss on drying |
Not more than 0.5% |
0.32% |
|
|
99.2% |
|
|
Contact us for more information
|
|
|
Packing 1 |
10g |
Packing 2 |
100g |
Packing 3 |
500g |
|
|
|
|
Bulk request |
sales@lanospharma.com |
|
|
|
|
|
|
PD1 |
Products protected by valid patents are not offered for sale in jurisdictions where the sale of such products constitutes a patent infringement. The current list only reflects the products and technologies that are available, under development: note that some products may be developed or produced for internal and experimental uses with no commercal aim. |
PD2 |
Sales of products are limited to those allowed by Chapter VII PLPRC 63, the above includes Research and development quantities. |
PD3 |
the buyer assumes responsibility of all patent considerations in the use of
Lanos' Pharmaceutical Co.,LTD ’s product(Dimercaptosuccinic acid,2418-14-6,99%,Antidotes). |
PD4 |
R&D use in accordance with (1) 35 USC 271(e)+A13(1) in the U.S.; (2) Section 69.1 of Japanese Patent Law in Japan; (3) Section 11, No. 2 of the German Patent Act of 1981 in Germany; (iv) Section 60, Paragraph 5b of the U.K. Patents Act of 1977 in the U.K.; (4) Sections 55.2(1) and 55.2(6) and other common law exemptions of Canadian patent law; (5) Section 68B of the Patents Act of 1953 in New Zealand together with the amendment of same by the Statutes Amendment Bill of 2002; (6) such related legislation and/or case law as may be or become applicable in the aforementioned countries; and (7) such similar laws and rules as may apply in various other countries.
|
|